Benzinga | Nov 2, 2020 07:17AM EST

Apellis Pharmaceuticals Q3 EPS $(1.79) Down From $(1.09) YoY

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(1.79) per share. This is a 64.22 percent decrease over losses of $(1.09) per share from the same period last year.